Divi's Lab.

{
  "main_header": {
    "sid": 509760,
    "name": "Divi's Lab.",
    "stock_name": "Divi's Lab.",
    "full_name": "Divis Laboratories Ltd",
    "name_url": "stocks-analysis/divi-s-lab",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "5,860.80",
    "chg": -46.15,
    "chgp": "-0.78%",
    "dir": -1,
    "prev_price": "5,906.95",
    "mcapval": "150,684.00 Cr",
    "mcap": "Large Cap",
    "scripcode": 532488,
    "symbol": "DIVISLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE361B01024",
    "curr_date": "Apr 02",
    "curr_time": "",
    "bse_nse_vol": "5.31 lacs",
    "exc_status": "Active",
    "traded_date": "Apr 02, 2026",
    "traded_date_str": "2026 04 02",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/divi-s-lab-509760-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Divis Laboratories Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-divis-laboratories-ltd-fallingrising-3931199",
        "imagepath": "",
        "date": "2026-04-03 01:25:03",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Divis Laboratories has experienced a consistent downward trend over the past week, with a one-week return of -2.53%, closely mirroring the Sensex’s decline of -2.60%. Over the last month, the stock has fallen by 8.47%, again tracking the benchmark’s 8.62% drop. Year-to-date, the stock is down 8.35%, though this is notably better than the Sensex’s 13.96% decline. Despite these short-term setbacks, the stock has delivered a positive 3.46% return over the past year, outperforming the Sensex’s negative 4.30% return. The longer-term performance is even more impressive, with a three-year gain of 107.41% compared to the Sensex’s 24.29%, and a five-year return of 62.12% against the benchmark’s 46.55%.</p>\n<p>On 02-Apr, the stock touched an int..."
      },
      {
        "title": "Divis Laboratories Ltd Hits Intraday Low Amid Price Pressure on 2 Apr 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-ltd-hits-intraday-low-amid-price-pressure-on-2-apr-2026-3929794",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/DivisLaboratori_priceRelatedfactors_3929794.png",
        "date": "2026-04-02 09:31:06",
        "description": "Shares of Divis Laboratories Ltd declined sharply on 2 Apr 2026, touching an intraday low of Rs 5,702, reflecting sustained price pressure amid a broadly weak market environment and sectoral downturn. The stock underperformed its Pharmaceuticals & Biotechnology sector peers and the broader Sensex index, continuing a recent trend of subdued performance."
      },
      {
        "title": "Divis Laboratories Sees Sharp Open Interest Surge Amid Bearish Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-sharp-open-interest-surge-amid-bearish-momentum-3929326",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/DivisLaboratori_oi_spurts_by_underlying_3929326.png",
        "date": "2026-04-01 15:00:12",
        "description": "Divis Laboratories Ltd (DIVISLAB), a large-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 10.8% increase in open interest in its derivatives segment, signalling heightened market activity despite the stock’s recent underperformance. This surge in open interest, coupled with volume patterns and price trends, offers critical insights into evolving market positioning and potential directional bets among investors."
      },
      {
        "title": "Divis Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/divis-laboratories-ltd-is-rated-sell-3922748",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/DivisLaboratori_mojoScore_3922748.png",
        "date": "2026-03-29 10:10:26",
        "description": "Divis Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 March 2026, providing investors with an up-to-date perspective on the company's fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Divis Laboratories Gains 0.57%: Mixed Signals Shape Weekly Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-gains-057-mixed-signals-shape-weekly-performance-3922575",
        "imagepath": "",
        "date": "2026-03-29 09:00:05",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>16 Mar:</strong> Technical downgrade signals bearish momentum</p>\n                    <p><strong>20 Mar:</strong> Intraday high surge of 3.0% to Rs.6,158.95</p>\n                    <p><strong>20 Mar:</strong> Week closes at Rs.6,102.25 (+0.57%) outperforming Sensex</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.6,067.60</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.6,102.25</div><div class=\"stat-change positive\">+0.57%</div></div>\n                    <div class=\"stat-item\"><div ..."
      },
      {
        "title": "Divis Laboratories Sees Sharp Open Interest Surge Amid Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-sharp-open-interest-surge-amid-mixed-technical-signals-3920055",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/DivisLaboratori_oi_spurts_by_underlying_3920055.png",
        "date": "2026-03-27 15:00:28",
        "description": "Divis Laboratories Ltd, a large-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 18.04% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a marginal price gain of 0.07%, the stock’s trading volumes and open interest dynamics suggest evolving directional bets amid a broader market downturn."
      },
      {
        "title": "Divis Laboratories Sees Sharp Open Interest Surge Amid Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-sharp-open-interest-surge-amid-mixed-technical-signals-3919844",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/DivisLaboratori_oi_spurts_by_underlying_3919844.png",
        "date": "2026-03-27 14:00:20",
        "description": "Divis Laboratories Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a modest price gain of 0.53% on 27 Mar 2026, the pharmaceutical giant’s futures and options data reveal a complex interplay of bullish and cautious bets amid broader sector and market headwinds."
      },
      {
        "title": "Divis Laboratories Sees Sharp Open Interest Surge Amid Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-sharp-open-interest-surge-amid-mixed-technical-signals-3919524",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/DivisLaboratori_oi_spurts_by_underlying_3919524.png",
        "date": "2026-03-27 13:00:12",
        "description": "Divis Laboratories Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a significant surge in open interest (OI) in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a modest price gain of 0.20% on 27 Mar 2026, the underlying dynamics suggest a complex interplay of directional bets and liquidity flows that merit close attention from investors and analysts alike."
      },
      {
        "title": "Divis Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-sharp-open-interest-surge-amid-mixed-market-signals-3916489",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/DivisLaboratori_oi_spurts_by_underlying_3916489.png",
        "date": "2026-03-25 15:00:34",
        "description": "Divis Laboratories Ltd, a large-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 15.11% surge in open interest in its derivatives segment, signalling increased market activity and shifting investor positioning. Despite this, the stock’s price performance remains subdued relative to its sector peers, reflecting a complex interplay of market sentiment and technical factors."
      }
    ],
    "total": 607,
    "sid": "509760",
    "stock_news_url": "https://www.marketsmojo.com/news/divis-laboratories-509760"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "31-Mar-2026",
      "details": "Intimation of closure of Trading Window from April 01 2026 till 48 hours of declaration of audited financial results for the quarter and financial year ended March 31 2026.",
      "source": "BSE"
    },
    {
      "caption": "Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "21-Mar-2026",
      "details": "Intimation about Draft Order issued under Section 144C(1) of the Income Tax Act 1961 for FY2022-23.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "14-Mar-2026",
      "details": "Newspaper clippings - Special Window for transfer and dematerialisation of physical shares.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Divis Laboratories Ltd has declared <strong>1500%</strong> dividend, ex-date: 25 Jul 25",
          "dt": "2025-07-25",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Divis Laboratories Ltd has announced <strong>2:10</strong> stock split, ex-date: 03 Aug 07",
          "dt": "2007-08-03",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Divis Laboratories Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 23 Sep 15",
          "dt": "2015-09-23",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Divis Laboratories Ltd falling/rising?

2026-04-03 01:25:03

Recent Price Movement and Market Context

Divis Laboratories has experienced a consistent downward trend over the past week, with a one-week return of -2.53%, closely mirroring the Sensex’s decline of -2.60%. Over the last month, the stock has fallen by 8.47%, again tracking the benchmark’s 8.62% drop. Year-to-date, the stock is down 8.35%, though this is notably better than the Sensex’s 13.96% decline. Despite these short-term setbacks, the stock has delivered a positive 3.46% return over the past year, outperforming the Sensex’s negative 4.30% return. The longer-term performance is even more impressive, with a three-year gain of 107.41% compared to the Sensex’s 24.29%, and a five-year return of 62.12% against the benchmark’s 46.55%.

On 02-Apr, the stock touched an int...

Read full news article

Divis Laboratories Ltd Hits Intraday Low Amid Price Pressure on 2 Apr 2026

2026-04-02 09:31:06

Shares of Divis Laboratories Ltd declined sharply on 2 Apr 2026, touching an intraday low of Rs 5,702, reflecting sustained price pressure amid a broadly weak market environment and sectoral downturn. The stock underperformed its Pharmaceuticals & Biotechnology sector peers and the broader Sensex index, continuing a recent trend of subdued performance.

Read full news article

Divis Laboratories Sees Sharp Open Interest Surge Amid Bearish Momentum

2026-04-01 15:00:12

Divis Laboratories Ltd (DIVISLAB), a large-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 10.8% increase in open interest in its derivatives segment, signalling heightened market activity despite the stock’s recent underperformance. This surge in open interest, coupled with volume patterns and price trends, offers critical insights into evolving market positioning and potential directional bets among investors.

Read full news article

Divis Laboratories Ltd is Rated Sell

2026-03-29 10:10:26

Divis Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 March 2026, providing investors with an up-to-date perspective on the company's fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Divis Laboratories Gains 0.57%: Mixed Signals Shape Weekly Performance

2026-03-29 09:00:05

Key Events This Week

16 Mar: Technical downgrade signals bearish momentum

20 Mar: Intraday high surge of 3.0% to Rs.6,158.95

20 Mar: Week closes at Rs.6,102.25 (+0.57%) outperforming Sensex

Week Open

Rs.6,067.60

Week Close

Rs.6,102.25

+0.57%

Read full news article

Divis Laboratories Sees Sharp Open Interest Surge Amid Mixed Technical Signals

2026-03-27 15:00:28

Divis Laboratories Ltd, a large-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 18.04% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a marginal price gain of 0.07%, the stock’s trading volumes and open interest dynamics suggest evolving directional bets amid a broader market downturn.

Read full news article

Divis Laboratories Sees Sharp Open Interest Surge Amid Mixed Technical Signals

2026-03-27 14:00:20

Divis Laboratories Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a modest price gain of 0.53% on 27 Mar 2026, the pharmaceutical giant’s futures and options data reveal a complex interplay of bullish and cautious bets amid broader sector and market headwinds.

Read full news article

Divis Laboratories Sees Sharp Open Interest Surge Amid Mixed Technical Signals

2026-03-27 13:00:12

Divis Laboratories Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a significant surge in open interest (OI) in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a modest price gain of 0.20% on 27 Mar 2026, the underlying dynamics suggest a complex interplay of directional bets and liquidity flows that merit close attention from investors and analysts alike.

Read full news article

Divis Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals

2026-03-25 15:00:34

Divis Laboratories Ltd, a large-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 15.11% surge in open interest in its derivatives segment, signalling increased market activity and shifting investor positioning. Despite this, the stock’s price performance remains subdued relative to its sector peers, reflecting a complex interplay of market sentiment and technical factors.

Read full news article

View All News